BlackRock Health Sciences Term Trust
About this Fund
BlackRock Health Sciences Term Trust is a leading mutual fund company specializing in asset management and investment solutions, dedicated to providing a diverse range of portfolio options to meet the evolving needs of investors. As a prominent player in the financial services industry, the company offers a broad spectrum of mutual funds, including equity, debt, and hybrid funds, each carefully crafted to cater to the unique objectives and risk tolerance of its investors. With a strong focus on wealth management, BlackRock Health Sciences Term Trust empowers investors to achieve their long-term financial goals through a systematic investment plan, or SIP, which enables them to invest a fixed amount of money at regular intervals, thereby promoting disciplined investing and mitigating the impact of market volatility. The company's investment strategy is centered around identifying high-growth potential opportunities in the healthcare sector, with a team of experienced professionals leveraging their expertise to create a well-diversified portfolio that balances risk and return. By combining rigorous research and analysis with a deep understanding of the market trends, BlackRock Health Sciences Term Trust is able to deliver consistent and sustainable investment performance, making it a trusted partner for investors seeking to navigate the complexities of the financial markets. With a commitment to transparency and accountability, the company provides investors with regular updates on their portfolio performance, enabling them to make informed decisions about their investments. BlackRock Health Sciences Term Trust's investor-centric approach has earned it a reputation as a reliable and customer-focused mutual fund company, with a strong emphasis on building long-term relationships with its clients. By prioritizing the needs and objectives of its investors, the company is able to tailor its investment solutions to meet their specific requirements, whether they are seeking aggressive growth, income generation, or capital preservation. The company's key strengths lie in its ability to leverage the expertise of its parent company, BlackRock, one of the world's largest asset management firms, while maintaining a specialized focus on the healthcare sector, which enables it to deliver unique insights and investment opportunities to its clients. As a result, investors trust BlackRock Health Sciences Term Trust to manage their wealth and help them achieve their financial aspirations, secure in the knowledge that their investments are being managed by a team of experienced professionals with a proven track record of success.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
2.06%
|
$22.00 | 175,604 |
| 2 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
1.28%
|
$13.66 | 59,784 |
| 3 | A Agilent Technologies Inc Since 2026-05-10 | 00846U101 | Equity (Common) |
1.58%
|
$16.88 | 124,041 |
| 4 | AGIO Agios Pharmaceuticals Inc Since 2026-05-10 | 00847X104 | Equity (Common) |
0.25%
|
$2.71 | 99,595 |
| 5 | ALLO Allogene Therapeutics Inc Since 2026-05-10 | 019770106 | Equity (Common) |
0.04%
|
$0.48 | 348,877 |
| 6 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
0.23%
|
$2.46 | 6,196 |
| 7 | COR Cencora Inc Since 2026-05-10 | 03073E105 | Equity (Common) |
0.49%
|
$5.20 | 15,383 |
| 8 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
1.39%
|
$14.82 | 45,282 |
| 9 | APGE Apogee Therapeutics Inc Since 2026-05-10 | 03770N101 | Equity (Common) |
0.29%
|
$3.08 | 40,862 |
| 10 | ACLX Arcellx Inc Since 2026-05-10 | 03940C100 | Equity (Common) |
0.32%
|
$3.40 | 52,210 |
| 11 | RCUS Arcus Biosciences Inc Since 2026-05-10 | 03969F109 | Equity (Common) |
0.37%
|
$3.95 | 165,805 |
| 12 | ARVN Arvinas Inc Since 2026-05-10 | 04335A105 | Equity (Common) |
0.11%
|
$1.12 | 94,854 |
| 13 | AZN AstraZeneca PLC Since 2026-05-10 | 046353108 | Equity (Common) |
1.00%
|
$10.64 | 115,738 |
| 14 | AVTX Avalo Therapeutics Inc Since 2026-05-10 | 05338F306 | Equity (Common) |
0.05%
|
$0.56 | 30,621 |
| 15 | AXSM Axsome Therapeutics Inc Since 2026-05-10 | 05464T104 | Equity (Common) |
0.49%
|
$5.25 | 28,760 |
| 16 | BEAM Beam Therapeutics Inc Since 2026-05-10 | 07373V105 | Equity (Common) |
0.20%
|
$2.13 | 76,864 |
| 17 | BIO-B Bio-Rad Laboratories Inc Since 2026-05-10 | 090572207 | Equity (Common) |
0.67%
|
$7.13 | 23,548 |
| 18 | BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 | 09061G101 | Equity (Common) |
0.18%
|
$1.88 | 31,662 |
| 19 | BIIB Biogen Inc Since 2026-05-10 | 09062X103 | Equity (Common) |
1.51%
|
$16.18 | 91,947 |
| 20 | BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 | 107924102 | Equity (Common) |
0.31%
|
$3.30 | 263,669 |
| 21 | BBIO Bridgebio Pharma Inc Since 2026-05-10 | 10806X102 | Equity (Common) |
0.98%
|
$10.46 | 136,783 |
| 22 | CRL Charles River Laboratories International Inc Since 2026-05-10 | 159864107 | Equity (Common) |
1.14%
|
$12.14 | 60,883 |
| 23 | COGT Cogent Biosciences Inc Since 2026-05-10 | 19240Q201 | Equity (Common) |
0.23%
|
$2.50 | 70,345 |
| 24 | DNLI Denali Therapeutics Inc Since 2026-05-10 | 24823R105 | Equity (Common) |
0.30%
|
$3.18 | 192,433 |
| 25 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
1.08%
|
$11.50 | 173,259 |
| 26 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.15%
|
$1.57 | 19,760 |
| 27 | DYN Dyne Therapeutics Inc Since 2026-05-10 | 26818M108 | Equity (Common) |
0.15%
|
$1.58 | 80,931 |
| 28 | EWTX Edgewise Therapeutics Inc Since 2026-05-10 | 28036F105 | Equity (Common) |
0.21%
|
$2.21 | 89,151 |
| 29 | ENTA Enanta Pharmaceuticals Inc Since 2026-05-10 | 29251M106 | Equity (Common) |
0.10%
|
$1.10 | 69,729 |
| 30 | ELVN Enliven Therapeutics Inc Since 2026-05-10 | 29337E102 | Equity (Common) |
0.08%
|
$0.84 | 54,885 |
| 31 | EXEL Exelixis Inc Since 2026-05-10 | 30161Q104 | Equity (Common) |
0.86%
|
$9.21 | 210,176 |
| 32 | EYPT EyePoint Inc Since 2026-05-10 | 30233G209 | Equity (Common) |
0.13%
|
$1.37 | 75,092 |
| 33 | FDMT 4D Molecular Therapeutics Inc Since 2026-05-10 | 35104E100 | Equity (Common) |
0.03%
|
$0.31 | 41,862 |
| 34 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
2.47%
|
$26.36 | 214,745 |
| 35 | GOSS Gossamer Bio Inc Since 2026-05-10 | 38341P102 | Equity (Common) |
0.02%
|
$0.19 | 60,195 |
| 36 | GH Guardant Health Inc Since 2026-05-10 | 40131M109 | Equity (Common) |
2.12%
|
$22.61 | 221,348 |
| 37 | HALO Halozyme Therapeutics Inc Since 2026-05-10 | 40637H109 | Equity (Common) |
0.40%
|
$4.25 | 63,226 |
| 38 | HRMY Harmony Biosciences Holdings Inc Since 2026-05-10 | 413197104 | Equity (Common) |
0.19%
|
$1.99 | 53,126 |
| 39 | HOLX Hologic Inc Since 2026-05-10 | 436440101 | Equity (Common) |
0.96%
|
$10.22 | 137,197 |
| 40 | ILMN Illumina Inc Since 2026-05-10 | 452327109 | Equity (Common) |
1.43%
|
$15.26 | 116,338 |
| 41 | IMNM Immunome Inc Since 2026-05-10 | 45257U108 | Equity (Common) |
0.14%
|
$1.53 | 71,450 |
| 42 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
1.25%
|
$13.35 | 23,573 |
| 43 | IONS Ionis Pharmaceuticals Inc Since 2026-05-10 | 462222100 | Equity (Common) |
1.10%
|
$11.76 | 148,696 |
| 44 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.99%
|
$10.54 | 46,747 |
| 45 | KALV KalVista Pharmaceuticals Inc Since 2026-05-10 | 483497103 | Equity (Common) |
0.11%
|
$1.14 | 70,390 |
| 46 | KOD Kodiak Sciences Inc Since 2026-05-10 | 50015M109 | Equity (Common) |
0.10%
|
$1.03 | 36,966 |
| 47 | KYMR Kymera Therapeutics Inc Since 2026-05-10 | 501575104 | Equity (Common) |
0.10%
|
$1.08 | 13,937 |
| 48 | LBRX LB Pharmaceuticals Inc Since 2026-05-10 | 50180M108 | Equity (Common) |
0.43%
|
$4.63 | 207,987 |
| 49 | LNTH Lantheus Holdings Inc Since 2026-05-10 | 516544103 | Equity (Common) |
0.30%
|
$3.21 | 48,294 |
| 50 | MBX MBX Biosciences Inc Since 2026-05-10 | 55287L101 | Equity (Common) |
0.38%
|
$4.05 | 128,549 |
| 51 | MAZE Maze Therapeutics Inc Since 2026-05-10 | 578784100 | Equity (Common) |
0.17%
|
$1.85 | 44,725 |
| 52 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
2.61%
|
$27.89 | 264,989 |
| 53 | MRNA Moderna Inc Since 2026-05-10 | 60770K107 | Equity (Common) |
1.09%
|
$11.69 | 396,289 |
| 54 | NTRA Natera Inc Since 2026-05-10 | 632307104 | Equity (Common) |
1.78%
|
$18.98 | 82,862 |
| 55 | NBIX Neurocrine Biosciences Inc Since 2026-05-10 | 64125C109 | Equity (Common) |
1.06%
|
$11.30 | 79,676 |
| 56 | NGNE Neurogene Inc Since 2026-05-10 | 64135M105 | Equity (Common) |
0.07%
|
$0.75 | 36,199 |
| 57 | NUVL Nuvalent Inc Since 2026-05-10 | 670703107 | Equity (Common) |
0.49%
|
$5.23 | 52,024 |
| 58 | NUVB Nuvation Bio Inc Since 2026-05-10 | 67080N101 | Equity (Common) |
0.24%
|
$2.54 | 283,833 |
| 59 | NUVB Nuvation Bio Inc Since 2026-05-10 | 67080N119 | Derivative |
0.00%
|
$0.02 | 68,880 |
| 60 | OCUL Ocular Therapeutix Inc Since 2026-05-10 | 67576A100 | Equity (Common) |
0.09%
|
$0.93 | 76,913 |
| 61 | OLMA Olema Pharmaceuticals Inc Since 2026-05-10 | 68062P106 | Equity (Common) |
0.23%
|
$2.48 | 98,993 |
| 62 | ORIC ORIC Pharmaceuticals Inc Since 2026-05-10 | 68622P109 | Equity (Common) |
0.08%
|
$0.81 | 99,005 |
| 63 | ORKA Oruka Therapeutics Inc Since 2026-05-10 | 687604108 | Equity (Common) |
0.14%
|
$1.47 | 48,426 |
| 64 | PTCT PTC Therapeutics Inc Since 2026-05-10 | 69366J200 | Equity (Common) |
0.24%
|
$2.61 | 34,361 |
| 65 | PEN Penumbra Inc Since 2026-05-10 | 70975L107 | Equity (Common) |
0.55%
|
$5.84 | 18,775 |
| 66 | NVS Novartis AG Since 2026-05-10 | — | Equity (Common) |
1.35%
|
$14.38 | 104,397 |
| 67 | PFE Pfizer Inc Since 2026-05-10 | 717081103 | Equity (Common) |
0.39%
|
$4.13 | 166,019 |
| 68 | PTGX Protagonist Therapeutics Inc Since 2026-05-10 | 74366E102 | Equity (Common) |
0.56%
|
$6.01 | 68,855 |
| 69 | RDNT RadNet Inc Since 2026-05-10 | 750491102 | Equity (Common) |
0.31%
|
$3.35 | 46,906 |
| 70 | RGNX REGENXBIO Inc Since 2026-05-10 | 75901B107 | Equity (Common) |
0.11%
|
$1.17 | 81,282 |
| 71 | RVMD Revolution Medicines Inc Since 2026-05-10 | 76155X100 | Equity (Common) |
0.35%
|
$3.74 | 46,968 |
| 72 | RZLT Rezolute Inc Since 2026-05-10 | 76200L309 | Equity (Common) |
0.02%
|
$0.26 | 108,605 |
| 73 | RYTM Rhythm Pharmaceuticals Inc Since 2026-05-10 | 76243J105 | Equity (Common) |
1.12%
|
$11.93 | 111,452 |
| 74 | SGMT Sagimet Biosciences Inc Since 2026-05-10 | 786700104 | Equity (Common) |
0.12%
|
$1.30 | 220,227 |
| 75 | STOK Stoke Therapeutics Inc Since 2026-05-10 | 86150R107 | Equity (Common) |
0.39%
|
$4.21 | 132,656 |
| 76 | SMMT Summit Therapeutics Inc Since 2026-05-10 | 86627T108 | Equity (Common) |
0.19%
|
$2.03 | 116,250 |
| 77 | TEM Tempus AI Inc Since 2026-05-10 | 88023B103 | Equity (Common) |
0.43%
|
$4.59 | 77,823 |
| 78 | TERN Terns Pharmaceuticals Inc Since 2026-05-10 | 880881107 | Equity (Common) |
0.53%
|
$5.67 | 140,311 |
| 79 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
0.49%
|
$5.25 | 9,062 |
| 80 | TCRX TScan Therapeutics Inc Since 2026-05-10 | 89854M101 | Equity (Common) |
0.04%
|
$0.41 | 407,010 |
| 81 | UPB Upstream Bio Inc Since 2026-05-10 | 91678A107 | Equity (Common) |
0.14%
|
$1.53 | 56,530 |
| 82 | VIR Vir Biotechnology Inc Since 2026-05-10 | 92764N102 | Equity (Common) |
0.05%
|
$0.50 | 82,723 |
| 83 | VOR Vor BioPharma Inc Since 2026-05-10 | 929033207 | Equity (Common) |
0.05%
|
$0.57 | 43,710 |
| 84 | VYGR Voyager Therapeutics Inc Since 2026-05-10 | 92915B106 | Equity (Common) |
0.05%
|
$0.56 | 141,787 |
| 85 | WST West Pharmaceutical Services Inc Since 2026-05-10 | 955306105 | Equity (Common) |
0.86%
|
$9.21 | 33,461 |
| 86 | NYXH Nyxoah SA Since 2026-05-10 | — | Equity (Common) |
0.05%
|
$0.52 | 112,019 |
| 87 | ALKS Alkermes PLC Since 2026-05-10 | — | Equity (Common) |
0.34%
|
$3.60 | 128,760 |
| 88 | BHVN Biohaven Ltd Since 2026-05-10 | — | Equity (Common) |
0.05%
|
$0.53 | 46,808 |
| 89 | KNSA Kiniksa Pharmaceuticals International Plc Since 2026-05-10 | — | Equity (Common) |
0.25%
|
$2.64 | 64,037 |
| 90 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
2.68%
|
$28.63 | 298,077 |
| 91 | ROIV Roivant Sciences Ltd Since 2026-05-10 | — | Equity (Common) |
0.49%
|
$5.22 | 240,456 |
| 92 | WVE WaVe Life Sciences Ltd Since 2026-05-10 | — | Equity (Common) |
0.15%
|
$1.64 | 96,283 |